![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 9/00 | (2006.01) |
A61K 9/08 | (2006.01) | ||
A61K 47/26 | (2006.01) | ||
A61K 39/395 | (2006.01) | ||
C07K 16/28 | (2006.01) | ||
A61K 47/12 | (2006.01) | ||
A61K 47/18 | (2017.01) |
(11) | Number of the document | 3256154 |
(13) | Kind of document | T |
(96) | European patent application number | 16703297.8 |
Date of filing the European patent application | 2016-02-05 | |
(97) | Date of publication of the European application | 2017-12-20 |
(45) | Date of publication and mention of the grant of the patent | 2019-10-02 |
(46) | Date of publication of the claims translation | 2020-01-10 |
(86) | Number | PCT/EP2016/052494 |
Date | 2016-02-05 |
(87) | Number | WO 2016/128318 |
Date | 2016-08-18 |
(30) | Number | Date | Country code |
15154301 | 2015-02-09 | EP |
(72) |
BOONEN, Michael Joseph Edouard, BE
PEERBOOM, Claude, BE
|
(73) |
UCB Biopharma SRL,
Allée de la Recherche 60, 1070 Brussels,
BE
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Farmacinė kompozicija, apimanti antikūną |
PHARMACEUTICAL FORMULATION COMPRISING ANTIBODY |
Payment date | Validity (years) | Amount | |
2025-01-02 | 10 | 231.00 EUR |
2026-02-05 |